{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"15.910","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"2,185,099,939","primaryexch":"香港交易所","ric":"1548.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":1.3963,"inline_upper_strike_price":"","sedol":"BD9Q2J2","am":"167.65","iv":"","ew_strike":"","as":"15.680","geographic_focus":null,"incorpin":"開曼群島","etp_baseCur":null,"ew_amt_os":"","bd":"15.660","registrar":"香港中央證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"2,000","update_time":"2025-09-28 00:06:03.0","lo52":"8.880","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"孟建革","underlying_ric":"1548.HK","hi52":"19.400","issuer_name":"金斯瑞生物科技股份有限公司","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"15.360","mkt_cap":"34.26","f_aum_hkd":null,"ew_sub_per_to":"","ls":"15.680","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"-0.200","aum":"","issued_shares_class_B":null,"vo":"10.75","secondary_listing_flag":false,"listing_date":"2015年12月30日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"金斯瑞生物科技股份有限公司","nm_s":"金斯瑞生物科技","sym":"1548","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"金斯瑞生物科技股份有限公司是一家主要從事生產及銷售生命科學研究產品及服務的投資控股公司。該公司通過五個分部開展業務。生命科學服務及產品分部提供全面的研究服務及產品。生物製劑開發服務分部以一個綜合平臺提供全面服務，旨在幫助生物製藥及生物技術公司加快治療性抗體及基因、細胞療法產品的開發。工業合成生物產品分部通過使用基因工程建構非病源微生物株，提供工業酶開發和生產。細胞療法分部發現和開發用於治療液體及固體腫瘤的CAR-T療法。經營管理分部主要為其他分部提供共享服務。該公司主要在中國國內和海外市場開展業務。","op":"15.580","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"生物技術","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"香港灣仔<br/>皇后大道東248號<br/>大新金融中心<br/>40樓","pc":"-1.26","days_to_expiry":null,"underlying_code":null,"pe":"1.45","eps_ccy":"USD","hdr":false,"launch_date":"","hc":"15.880","isin":"KYG3825B1059","moneyness":""}},"qid":"1759074102356"}
